Meeting details

PIRAMAL PHARMA LIMITED



Proposal 1
TO RECEIVE, CONSIDER AND ADOPT THE AUDITED FINANCIAL STATEMENTS (STANDALONE AND CONSOLIDATED) OF THE COMPANY FOR THE FINANCIAL YEAR ENDED MARCH 31, 2023 AND THE REPORTS OF THE BOARD OF DIRECTORS AND AUDITORS THEREON

Caisse vote:
For

Applicable policy or principle:
PC_00


Proposal 2
TO APPOINT A DIRECTOR IN PLACE OF MR. NEERAJ BHARADWAJ (DIN: 01314963), WHO RETIRES BY ROTATION AND BEING ELIGIBLE, OFFERS HIMSELF FOR RE-APPOINTMENT

Caisse vote:
For

Applicable policy or principle:
PC_00


Proposal 3
RE-APPOINTMENT OF MR. PETER DEYOUNG AS EXECUTIVE DIRECTOR OF THE COMPANY

Caisse vote:
For

Applicable policy or principle:
PC_00


Proposal 4
RE-APPOINTMENT OF MS. NANDINI PIRAMAL AS CHAIRPERSON OF THE COMPANY

Caisse vote:
For

Applicable policy or principle:
PC_00


Proposal 5
AMENDMENT OF ARTICLES OF ASSOCIATION OF THE COMPANY

Caisse vote:
For

Applicable policy or principle:
PC_00


Proposal 6
ISSUE OF NON-CONVERTIBLE DEBENTURES ON PRIVATE PLACEMENT BASIS

Caisse vote:
For

Applicable policy or principle:
PC_00


Proposal 7
RATIFICATION OF REMUNERATION PAYABLE TO MS. G. R. KULKARNI AND ASSOCIATES, COST ACCOUNTANTS, MUMBAI (REGISTRATION NO. 00168), AS COST AUDITORS

Caisse vote:
For

Applicable policy or principle:
PC_00

See all shareholders' meetings for this company